Cardiac safety case studies
How we assess cardiac safety risks at all stages of clinical development
Explore our library of expertise on cardiac safety.
Comprehensive cardiac safety monitoring solutions that deliver accurate cardiac data, supporting decisions across all phases of drug and device development.
Strategic site selection and endpoint integrity in hypertrophic cardiomyopathy trials
91黑料 enabled successful enrollment and data integrity in two global Phase 3 HCM trials through expert site selection and CPET standardization. Despite rare disease challenges and competitor pressure, the program advanced smoothly.
Patient cardiac safety
A digital health lead at a large pharmaceutical company came to 91黑料 Outcome Measures to find a wearable that could capture continuous cardiac rhythms and be used to detect QT prolongation.
Cardiac imaging and monitoring support for PAH trial
91黑料 provided a large pharma sponsor with consistent, accurate ECG and ECHO modality imaging, contributing to a breakthrough pulmonary arterial hypertension treatment.
Cardiovascular safety in a rare disease study
A biotech company sought 91黑料's help to analyse and report on a limited data set to demonstrate cardiovascular safety in a rare disease study.